Viant Medical, Inc.

Viant Medical, Inc. is a US-based company specializing in the design and manufacturing of medical devices, dedicated solely to the medical technology sector with a focus on enhancing patient outcomes through innovative solutions. Viant Medical, Inc. is dedicated to comprehensive medical device design and manufacturing.

Founded in 2007 and headquartered in Foxborough, US, the company has undergone strategic changes over the years, including an acquisition by JLL Partners and Water Street Healthcare Partners in December 2016, acquiring it from investor groups including Baird Capital Partners. The current CEO is Christian Geppert. Viant specializes in comprehensive medical device design and manufacturing, focusing exclusively on the medical technology sector. Their core offerings encompass a wide array of solutions, including device assembly, tooling, materials expertise, and advanced manufacturing capabilities such as overmolding and nitinol tubing.

Viant is noted for its substantial experience in orthopedics, supplying instruments, implants, and delivery systems, while also leading in UHMWPE components through its orthoplastics group. Their expertise extends into surgical technologies, encompassing minimally invasive surgery, robotics, endoscopy, and various clinical markets such as cardiac and interventional devices, bioelectronics, and respiratory devices. Viant’s products serve a global market, addressing the needs of original equipment manufacturers (OEMs) in North America, Europe, and Asia, with an emphasis on enhancing patient and provider outcomes across diverse healthcare applications. Viant generates revenue through B2B transactions, primarily with original equipment manufacturers (OEMs) in the medical device sector.

Their business model involves providing end-to-end manufacturing solutions, which includes services such as device assembly, packaging, and sterilization management. Transactions typically occur on a contractual basis, where clients engage Viant for specific projects or ongoing manufacturing partnerships. For instance, clients may partner with Viant for the production of precision hypotube components or for advanced manufacturing of surgical instruments, leveraging Viant’s expertise and capacity. Pricing structures are determined based on the specific services rendered, with the potential for long-term agreements ensuring consistent revenue streams as clients rely on Viant for their specialized manufacturing needs.

Viant Medical, Inc. aims to expand its product offerings and market presence by developing new medical devices and technologies tailored to emerging healthcare needs. The company is targeting growth in international markets, specifically in Europe and Asia, by 2025. The proceeds from the recent acquisition in December 2016 will facilitate investments in research and development, allowing Viant to enhance its manufacturing capabilities and support the launch of innovative products that address current and future medical challenges.